MedPath

Prospective, multicenter, single-arm, open study for post market clinical follow-up and evaluation of safety and performance of MORCHER® Capsular Rings during clinical routine

Conditions
H28
Cataract and other disorders of lens in diseases classified elsewhere
Registration Number
DRKS00015295
Lead Sponsor
MORCHER® GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting stopped after recruiting started
Sex
All
Target Recruitment
37
Inclusion Criteria

1. The Patient receives cataract surgery of one or both eyes.
2. The Patient receives a MORCHER® Capsular Ring according to the Instruction for Use (IFU).
3. The Patient has freely given his consent in written form to take part in the study, that is to use patient´s clinical data within the study.
4. The Patient is willing and able to take part in control examinations at the study site. The patient has been informed that participation in the control examinations at the study site is voluntary.
5. The corresponding eye receives cataract surgery and a MORCHER® Capsular Ring according to the IFU.
6. The corresponding eye has one of the following indications:
• High myopia
Additional indications only for capsular tension rings and Cionni rings
• With zonulolysis
• In pseudoexfoliation
• Primary zonular weakness
• Defective or missing zonules
Additional indications only for capsular tension rings
• Marchesani syndrome
Additional indications only for Cionni rings
• Secondary zonular weakness (e.g. Marfans’s syndrome)

Exclusion Criteria

1. The patient and/or the corresponding eye has a contraindication according to the IFU.
2. The eyes of the patient are not fully developed and/or the patient is younger than 18 years.
3. The MORCHER® Capsular Ring is used „off label (sometimes referred to as „compassionate use), that is beyond of its intended use.
4. The patient is vulnerable.
5. The patient participates in one or several interventional studies.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of centering of the intraocular lens after cataract surgery
Secondary Outcome Measures
NameTimeMethod
1) Assessment of Tension folds within the capsular bag, <br>2) Documentation of tretament-associated adverse Events
© Copyright 2025. All Rights Reserved by MedPath